Tilray Brands, Inc. Equity Securities, FV-NI, Unrealized Loss
Tilray Brands, Inc. (TLRY) reported Equity Securities, FV-NI, Unrealized Loss of $4.28 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesFvNiUnrealizedLoss · last filed 2021-02-19
- Tilray Brands, Inc. equity securities, fv-ni, unrealized loss for fiscal 2020 was $4.28M, a 356.12% increase from fiscal 2019.
- Tilray Brands, Inc. equity securities, fv-ni, unrealized loss for fiscal 2019 was $939.00K.
| Period end | Equity Securities, FV-NI, Unrealized Loss 12 month |
|---|---|
| 2020-12-31 | $4.28M 10-K · filed 2021-02-19 |
| 2019-12-31 | $939.00K 10-K · filed 2021-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |